Phenylketonuria: questioning the gospel.

Area of Science:

• Metabolic Disorders
• Genetics
• Biochemistry

Background:

• Phenylketonuria (PKU) is a genetic disorder with a long history of research and treatment development.
• Phenylalanine-restricted diets have been effective in preventing intellectual disability in individuals with PKU.
• Current treatments, while beneficial, have limitations, particularly in later life stages.

Purpose of the Study:

• To review the historical context and current state of PKU management.
• To explore emerging alternative treatment strategies beyond dietary restrictions.
• To highlight the need for improved long-term care and research for PKU patients.

Main Methods:

• Review of historical data and published literature on PKU treatment.
• Analysis of current therapeutic approaches, including dietary management and emerging therapies.
• Discussion of challenges in late childhood, adolescence, and adulthood PKU care.

Main Results:

• Dietary management has successfully prevented severe intellectual disability in many PKU cases.
• The effectiveness of dietary control diminishes in later life stages.
• New treatment avenues such as large neutral amino acids, phenylalanine ammonia lyase, tetrahydrobiopterin, and gene therapy are under investigation.
• Potential nutrient deficiencies in low-protein diets and the efficacy of late-initiated maternal PKU treatment have been noted.

Conclusions:

• While phenylalanine-restricted diets are foundational, alternative treatments are crucial for optimizing PKU management.
• Addressing nutritional deficits and establishing dedicated adult treatment centers are essential for comprehensive PKU care and research.
• Continued research is vital to improve outcomes for individuals with PKU across their lifespan.